Why the study?
Does multivessel treatment during primary angioplasty improve clinical or economical outcomes compared to culprit-lesion-only treatment in patients with acute myocardial infarction?
Does multivessel treatment during primary angioplasty improve clinical or economical outcomes compared to culprit-lesion-only treatment in patients with acute myocardial infarction?
A staged approach to multivessel treatment during primary angioplasty for AMI is preferred, as initial aggressive multivessel stenting offers no additional clinical or economic advantages.
No takes yet. Share an insight, caveat, or question.
Favors culprit-only or staged PCI in multivessel AMI; reinforces guidelines against routine immediate multivessel intervention.
Mario et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: